# Impact of Neutral Sphingomyelinase Inhibition on Small Extracellular Vesicle Production by Mural Granulosa Cells and In Vitro Folliculogenesis in Mice

**Authors:** Kodai Matsushita, Yuta Matsuno, Kazuma Kita, Ayaka Ichikawa, Natsumi Maruyama, Wataru Fujii, Tsutomu Endo, Koji Sugiura

PMC · DOI: 10.1002/mrd.70063 · Molecular Reproduction and Development · 2025-10-16

## TL;DR

This study shows that inhibiting neutral sphingomyelinase reduces small extracellular vesicle production in granulosa cells, which affects follicle development and estrogen-related gene expression in mice.

## Contribution

The study identifies nSMase activity as critical for sEV production in mural granulosa cells and links sEVs to regulation of Cyp19a1 expression.

## Key findings

- GW4869 treatment reduced sEV production in mural granulosa cell cultures.
- nSMase inhibition impaired in vitro follicle development and lowered Cyp19a1 expression.
- Adding sEVs from granulosa cells increased Cyp19a1 expression.

## Abstract

Small extracellular vesicles (sEVs) function as critical regulators of ovarian follicular development. Although several pathways, including one involving neutral sphingomyelinase (nSMase), contribute to sEV production, the specific pathway active in ovarian follicles has not been clearly identified. In this study, we investigated GW4869, a specific inhibitor of nSMase activity, to determine its impact on sEV production by mouse mural granulosa cells (MGCs), the primary source of follicular sEVs. We also examined how nSMase inhibition affects the in vitro growth of oocyte‒granulosa cell complexes (OGCs) derived from secondary follicles. Transcripts encoding nSMases (Smpd2 and Smpd4) were detected in MGCs, and GW4869 treatment significantly reduced sEV production in MGC monolayer cultures. Control OGCs developed into antral follicle‐like structures, with the antrum‐like structure separating granulosa cells into cumulus‐like and MGC‐like cells. However, GW4869 treatment impaired OGC development. MGC‐like cells from GW4869‐treated OGCs exhibited significantly lower Cyp19a1 levels, whereas adding MGC‐derived sEVs promoted Cyp19a1 expression. These results suggest that nSMase activity, likely involving Smpd2 and Smpd4, is required for sEV production by MGCs and that follicular sEVs may regulate Cyp19a1 expression in MGCs.

## Linked entities

- **Genes:** SMPD2 (sphingomyelin phosphodiesterase 2) [NCBI Gene 6610], SMPD4 (sphingomyelin phosphodiesterase 4) [NCBI Gene 55627], CYP19A1 (cytochrome P450 family 19 subfamily A member 1) [NCBI Gene 1588]
- **Chemicals:** GW4869 (PubChem CID 6476900)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Smpd2 (sphingomyelin phosphodiesterase 2, neutral) [NCBI Gene 20598] {aka nSMase, nSMase1}, Smpd4 (sphingomyelin phosphodiesterase 4) [NCBI Gene 77626] {aka 4122402O22Rik}, Cyp19a1 (cytochrome P450, family 19, subfamily a, polypeptide 1) [NCBI Gene 13075] {aka Ar, ArKO, Cyp19, Int-5, Int5, p450arom}
- **Diseases:** MGC (MESH:D006627)
- **Chemicals:** GW4869 (MESH:C468773)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12529890/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12529890/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12529890/full.md

---
Source: https://tomesphere.com/paper/PMC12529890